Literature DB >> 24791950

The contribution of the functional IL6R polymorphism rs2228145, eQTLs and other genome-wide SNPs to the heritability of plasma sIL-6R levels.

Jenny van Dongen1, Rick Jansen, Dirk Smit, Jouke-Jan Hottenga, Hamdi Mbarek, Gonneke Willemsen, Cornelis Kluft, Brenda W J Penninx, Manuel A Ferreira, Dorret I Boomsma, Eco J C de Geus.   

Abstract

The non-synonymous SNP rs2228145 in the IL6R gene on chromosome 1q21.3 is associated with a wide range of common diseases, including asthma, rheumatoid arthritis, type 1 diabetes and coronary heart disease. We examined the contribution of this functional IL6R gene polymorphism rs2228145 versus other genome-wide SNPs to the variance of sIL-6R levels in blood plasma in a large population-based sample (N ~5,000), and conducted an expression QTL analysis to identify SNPs associated with IL6R gene expression. Based on data from 2,360 twin families, the broad heritability of sIL-6R was estimated at 72 and 51% of the total variance was explained by the functional SNP rs2228145. Converging findings from GWAS, linkage, and GCTA analyses indicate that additional variance of sIL-6R levels can be explained by other variants in the IL6R region, including variants at the 3'-end of IL6R tagged by rs60760897 that are associated with IL6R RNA expression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24791950      PMCID: PMC4283105          DOI: 10.1007/s10519-014-9656-8

Source DB:  PubMed          Journal:  Behav Genet        ISSN: 0001-8244            Impact factor:   2.805


  55 in total

1.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

2.  Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins.

Authors:  A Mackiewicz; H Schooltink; P C Heinrich; S Rose-John
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

3.  Best linear unbiased allele-frequency estimation in complex pedigrees.

Authors:  Mary Sara McPeek; Xiaodong Wu; Carole Ober
Journal:  Biometrics       Date:  2004-06       Impact factor: 2.571

4.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130.

Authors:  T Taga; M Hibi; Y Hirata; K Yamasaki; K Yasukawa; T Matsuda; T Hirano; T Kishimoto
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

5.  Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.

Authors:  R Atreya; J Mudter; S Finotto; J Müllberg; T Jostock; S Wirtz; M Schütz; B Bartsch; M Holtmann; C Becker; D Strand; J Czaja; J F Schlaak; H A Lehr; F Autschbach; G Schürmann; N Nishimoto; K Yoshizaki; H Ito; T Kishimoto; P R Galle; S Rose-John; M F Neurath
Journal:  Nat Med       Date:  2000-05       Impact factor: 53.440

6.  Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor.

Authors:  J A Lust; K A Donovan; M P Kline; P R Greipp; R A Kyle; N J Maihle
Journal:  Cytokine       Date:  1992-03       Impact factor: 3.861

Review 7.  The soluble interleukin 6 receptor: mechanisms of production and implications in disease.

Authors:  S A Jones; S Horiuchi; N Topley; N Yamamoto; G M Fuller
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

8.  Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo.

Authors:  M Saito; K Yoshida; M Hibi; T Taga; T Kishimoto
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

9.  TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling.

Authors:  Christoph Becker; Massimo C Fantini; Christoph Schramm; Hans A Lehr; Stefan Wirtz; Alexei Nikolaev; Jürgen Burg; Susanne Strand; Ralf Kiesslich; Samuel Huber; Hiroaki Ito; Norihiro Nishimoto; Kazuyuki Yoshizaki; Tadamitsu Kishimoto; Peter R Galle; Manfred Blessing; Stefan Rose-John; Markus F Neurath
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

10.  Polymorphisms in the IL-6 receptor (IL-6R) gene: strong evidence that serum levels of soluble IL-6R are genetically influenced.

Authors:  J C Galicia; H Tai; Y Komatsu; Y Shimada; K Akazawa; H Yoshie
Journal:  Genes Immun       Date:  2004-09       Impact factor: 2.676

View more
  18 in total

Review 1.  Genetics of Thoracic and Abdominal Aortic Diseases.

Authors:  Amélie Pinard; Gregory T Jones; Dianna M Milewicz
Journal:  Circ Res       Date:  2019-02-15       Impact factor: 17.367

2.  Genetic and environmental determinants of population variation in interleukin-6, its soluble receptor and C-reactive protein: insights from identical and fraternal twins.

Authors:  Wellington Z Amaral; Robert F Krueger; Carol D Ryff; Christopher L Coe
Journal:  Brain Behav Immun       Date:  2015-06-15       Impact factor: 7.217

3.  Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression.

Authors:  Christian Hundhausen; Alena Roth; Elizabeth Whalen; Janice Chen; Anya Schneider; S Alice Long; Shan Wei; Rebecca Rawlings; MacKenzie Kinsman; Stephen P Evanko; Thomas N Wight; Carla J Greenbaum; Karen Cerosaletti; Jane H Buckner
Journal:  Sci Transl Med       Date:  2016-09-14       Impact factor: 17.956

Review 4.  IL-6: a cytokine at the crossroads of autoimmunity.

Authors:  Britta E Jones; Megan D Maerz; Jane H Buckner
Journal:  Curr Opin Immunol       Date:  2018-09-21       Impact factor: 7.486

5.  Effect of genome and environment on metabolic and inflammatory profiles.

Authors:  Marina Sirota; Gonneke Willemsen; Purnima Sundar; Steven J Pitts; Shobha Potluri; Edi Prifti; Sean Kennedy; S Dusko Ehrlich; Jacoline Neuteboom; Cornelis Kluft; Karen E Malone; David R Cox; Eco J C de Geus; Dorret I Boomsma
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Decreased expression levels of Ifi genes is associated to the increased resistance to spontaneous arthritis disease in mice deficiency of IL-1RA.

Authors:  Xiaoyun Liu; Yan Jiao; Yanhong Cao; Nan Deng; Yonghui Ma; Karen A Hasty; Andrew Kang; Hong Chen; John M Stuart; Weikuan Gu
Journal:  BMC Immunol       Date:  2016-08-02       Impact factor: 3.615

7.  Causes of variation in the neutrophil-lymphocyte and platelet-lymphocyte ratios: a twin-family study.

Authors:  Bochao D Lin; Jouke-Jan Hottenga; Abdel Abdellaoui; Conor V Dolan; Eco J C de Geus; Cornelis Kluft; Dorret I Boomsma; Gonneke Willemsen
Journal:  Biomark Med       Date:  2016-10-03       Impact factor: 2.851

8.  Tocilizumab is safe and tolerable and reduces C-reactive protein concentrations in the plasma and cerebrospinal fluid of ALS patients.

Authors:  Carol Milligan; Nazem Atassi; Suma Babu; Richard J Barohn; James B Caress; Merit E Cudkowicz; Armineuza Evora; Gregory A Hawkins; Marlena Wosiski-Kuhn; Eric A Macklin; Jeremy M Shefner; Zachary Simmons; Robert P Bowser; Shafeeq S Ladha
Journal:  Muscle Nerve       Date:  2021-06-24       Impact factor: 3.852

Review 9.  Lessons from ten years of genome-wide association studies of asthma.

Authors:  Cristina T Vicente; Joana A Revez; Manuel A R Ferreira
Journal:  Clin Transl Immunology       Date:  2017-12-15

10.  Mendelian Randomization Analysis Identifies CpG Sites as Putative Mediators for Genetic Influences on Cardiovascular Disease Risk.

Authors:  Tom G Richardson; Jie Zheng; George Davey Smith; Nicholas J Timpson; Tom R Gaunt; Caroline L Relton; Gibran Hemani
Journal:  Am J Hum Genet       Date:  2017-10-05       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.